Guru Ownership Trend
Guru Analysis for ARS Pharmaceuticals, Inc. (SPRY)
ARS Pharmaceuticals, Inc. (SPRY), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q3 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $3.9 M.
Top institutional holders include Daniel Loeb and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $584,157.08 net inflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 173.1%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q3 2026)
Guru Consensus (Q3 2026)
FAQs for ARS Pharmaceuticals, Inc. (SPRY)
Major holders include Daniel Loeb ($4.31 M), Renaissance Technologies (RenTech) ($750,802), Cliff Asness ($419,851). According to the latest reported data, 4 tracked investment managers collectively hold approximately 1.32 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $584,157.08, with 2 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 0 managers trimmed their positions, while 1 fully exited SPRY. The total reported sell value was $432,732.
Yes, 1 managers opened new positions in SPRY, and 1 increased their existing holdings. The total reported buy value was $1.02 M.